The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska Institutet and the University of Verona argue that the rest of these E3 ligases are where the next generation of cancer drugs will be found.
❓ Unknown
Molecular glues: Unlocking new targets in cancer
Just now
November 20, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
This article discusses cancer drug development research focusing on E3 ligases, published by researchers at Karolinska Institutet and University of Verona. It has no direct connection to Iran, Iranian politics, or Iranian affairs.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
5 min ago •
CITEX Exhibition Displays Iranian Smart City Technologies and Urban Innovation Solutions
8 min ago •
Space travel changes the brain's immune cells, but not behavior
8 min ago •